(News Bulletin 247) – Specialized in bio-analytical services, the group has excellent fundamentals. Its valuation has fallen as fundamentals improve with revenue growth in particular. The worst appears to be price by operators after the publication below expectations in early March.

KEY GRAPHIC ELEMENTS

The stock has been in a range for more than a month. The presence of buying volumes and the return towards the upper limit of the range with force and speed indicates that the buyers could take control of the operations. We can therefore anticipate the exit from the top of this accumulation phase on a long-term support zone to aim for a filling of the gap (price hole) initially then the resistance zone of €70 in a second phase.

FORECAST

Considering the key chart factors we have mentioned, our view is bullish on EUROFINS SCIENT stock. short term.

Active investors will take a buying position on the EUROFINS SCIENT stock. at €62,720 with a target of €70,000 in sight. They will protect their capital by placing a stop at €58,600.

The News Bulletin 247 board

EUROFINS SCIENT.
Positive 62.720 €
Objective :
€70,000
Potential :
+11.61%
Stop:
€58,600
Resistance(s):
65,560 / 69,100 / 70,000
Medium(s):
61,600 / 57,900

CHART IN DAILY DATA

Graphic made from the software Prorealtime



function creatOutbrainJs() {
const creatJs = document.createElement(“script”);
creatJs.defer = true;
creatJs.src = “https://widgets.outbrain.com/outbrain.js”;
return document.body.appendChild(creatJs);
}

window.didomiOnReady = window.didomiOnReady || [];

window.didomiOnReady.push(function(Didomi) {
console.log(“Didomi ready “);

Didomi.getObservableOnUserConsentStatusForVendor(164)
.filter(function (status) { return status !== undefined })
.subscribe(function(consentStatus) {
if (consentStatus === false || consentStatus === true) {
console.log(“Didomi consent -> exécution du script outbrain “, consentStatus);
creatOutbrainJs()
}
});

});